Cargando…
Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs
Myasthenia gravis (MG) with antibodies against the acetylcholine receptor (AChR) is characterized by a chronic, fatigable weakness of voluntary muscles. The production of autoantibodies involves the dysregulation of T cells which provide the environment for the development of autoreactive B cells. T...
Autores principales: | Losen, Mario, Martinez-Martinez, Pilar, Molenaar, Peter C., Lazaridis, Konstantinos, Tzartos, Socrates, Brenner, Talma, Duan, Rui-Sheng, Luo, Jie, Lindstrom, Jon, Kusner, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466156/ https://www.ncbi.nlm.nih.gov/pubmed/25796590 http://dx.doi.org/10.1016/j.expneurol.2015.03.010 |
Ejemplares similares
-
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020) -
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020) -
Protease effects on the structure of acetylcholine receptor membranes from Torpedo californica
Publicado: (1980) -
Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
por: Saxena, Abhishek, et al.
Publicado: (2017) -
A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis
por: Lazaridis, Konstantinos, et al.
Publicado: (2022)